Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

In vitroα1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel α1A-adrenoceptor selective antagonists.

Autor: Williams, T J, Blue, D R, Daniels, D V, Davis, B, Elworthy, T, Gever, J R, Kava, M S, Morgans, D, Padilla, F, Tassa, S, Vimont, R L, Chapple, C R, Chess-Williams, R, Eglen, R M, Clarke, D E, Ford, A P D W

Publikováno v: British Journal of Pharmacology; May1999, Vol. 127 Issue 1, p252-258, 7p

Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence.

Autor: Blue DR; Roche Palo Alto, Palo Alto, CA, USA. dave.blue@roche.com, Daniels DV, Gever JR, Jett MF, O'Yang C, Tang HM, Williams TJ, Ford AP

Publikováno v: BJU international [BJU Int] 2004 Jan; Vol. 93 (1), pp. 162-70.

In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.

Autor: Williams TJ; New Leads Discovery, Center for Biological Research, Neurobiology Unit, Roche Bioscience, Palo Alto, California 94304, USA. tim.williams@roche.com, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, Vimont RL, Chapple CR, Chess-Williams R, Eglen RM, Clarke DE, Ford AP

Publikováno v: British journal of pharmacology [Br J Pharmacol] 1999 May; Vol. 127 (1), pp. 252-8.

Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms.

Autor: Chang DJ; Center for Biological Research, Neurobiology Unit, Roche Bioscience, Palo Alto, CA 94304, USA. david-j.chang@roche.com, Chang TK, Yamanishi SS, Salazar FH, Kosaka AH, Khare R, Bhakta S, Jasper JR, Shieh IS, Lesnick JD, Ford AP, Daniels DV, Eglen RM, Clarke DE, Bach C, Chan HW

Publikováno v: FEBS letters [FEBS Lett] 1998 Jan 30; Vol. 422 (2), pp. 279-83.